Acute diuretic effect of ethanolic and aqueous extracts of Ceratopteris pteridoides (Hook) in normal rats;Efecto diurético agudo de los extractos etanólico y acuoso de Ceratopteris pteridoides (Hook) en ratas normales

Biomedica

Volumn 33, Issue 1, 2013, Pages 115-121

  Alviz, Antistio Aníbal ^a   Salas, Rubén Darío ^a   Franco, Luis Alberto ^a  

^a UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Diuretics; Electrolytes; Furosemide; Medicinal; Plants

Indexed keywords

EID: 84884376519     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52. http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2
2. Jentzer JC, DeWald TA, Hernández AF. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010;56:1527-34. http://dx.doi.org/10.1016/j.jacc.2010.06.034,
3. Lacourcière Y, Poirier L, Lefebvre J, Ross SA, Leenen FH. Increasing the doses of both diuretics and angiotensin receptor blockers is beneficial in subjects with uncontrolled systolic hypertension. Can J Cardiol. 2010;26:e313-9.
4. Sadki C, Hacht B, Souliman A, Atmani F. Acute diuretic activity of aqueous Erica multiflora flowers and Cynodon dactylon rhizomes extracts in rats. J Ethnopharmacol. 2010;128:352-6. http://dx.doi.org/10.1016/j.jep.2010.01.048
5. Gupta S, Neyses L. Diuretic usage in heart failure: A continuing conundrum in 2005. Eur Heart J. 2005;26:644-9. http://dx.doi.org/10.1093/eurheartj/ehi176
6. Morganti A. Should a diuretic always be the first choice in patients with essential hypertension? The case for no. J Am Soc Nephrol. 2005;16(Suppl.1):S70-3. http://dx.doi.org/10.1681/ASN.2004110964
7. Cleland JGF, Coletta A, Witte K. Practical applications of intravenous diuretic therapy in decompensated heart failure. Am J Med. 2006;119:S26-36. http://dx.doi.org/10.1016/j.amjmed.2006.09.014
8. Clark AM. Natural products as a resource for new drugs. Pharm Res. 1996;13:1133-41.
9. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 2003;66:1022-37. http://dx.doi.org/10.1021/np030096l
10. Delascio Chitty F. Helechos acuáticos del Estado de Cojedes (Venezuela). An Jard Bot Madr. 1980;36:61-7.
11. Gemmrich AR. Fatty acid composition of fern spore lipids. Phytochemistry. 1977;16:1044-6.
12. Kau S, Keddie J, Andrews D. A method for screening diuretic agents in the rat. J Pharmacol Methods. 1984;11:67- 75. http://dx.doi.org/10.1016/0160-5402(84)90054-8
13. Lahlou S, Tahraoui A, Israili Z, Lyoussi B. Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats. J Ethnopharmacol. 2007;110:458-63. http://dx.doi.org/10.1016/j.jep.2006.10.005
14. Martín-Herrera D, Abdala S, Benjumea D, Pérez-Paz P. Diuretic activity of Withania aristata: An endemic Canary Island species. J Ethnopharmacol. 2007;113:487-91. http://dx.doi.org/10.1016/j.jep.2007.07.005
15. Allen T, Prophet E. Métodos histotecnológicos: hematoxilina y eosina. Washington, D.C.: Instituto de Patología de las Fuerzas Armadas (AFIP); 1995. p. 55-60.
16. Shah SU, Anjum S, Littler WA. Use of diuretics in cardiovascular diseases: (1) Heart failure. Postgrad Med J. 2004;80:201-5. http://dx.doi.org/10.1136/pgmj.2003.010835
17. Kalant H, Roschlau WHE, Monsiváis RIS, Ackermann U. Principios de farmacología médica. 6a edición. Oxford: Universidad Iberoamericana; 2002. p. 525-39.
18. Rosner MH, Gupta R, Ellison D, Okusa MD. Management of cirrhotic ascites: Physiological basis of diuretic action. Eur J Intern Med. 2006;17:8-19. http://dx.doi.org/10.1016/j.ejim.2005.08.003
19. Nedi T, Mekonnen N, Urga K. Diuretic effect of the crude extracts of Carissa edulis in rats. J Ethnopharmacol. 2004;95:57-61. http://dx.doi.org/10.1016/j.jep.2004.06.017,
20. Hirano T, Yamamura Y, Nakamura S, Onogawa T, Mori T. Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. J Pharmacol Exp Ther. 2000;292:288-94.
21. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099-112. http://dx.doi.org/10.1056/NEJMoa065181
22. Abreu CC, Fabián MG, Narváez O. Tratamiento actual de la insuficiencia cardiaca aguda descompensada. Revista Mexicana de Cardiología. 2006;17:106-9.
23. Soeder RW. Fern constituents: Including occurrence, chemotaxonomy and physiological activity. Bot Rev. 1985;51:442-536. http://dx.doi.org/10.1007/BF02860970